Oregon's biopharmaceutical companies research and develop new treatments and cures that improve patient health while also contributing to U.S. economic health. These companies employ highly skilled union construction workers to build state-of-the-art research and manufacturing facilities to ensure infrastructure is built to exacting standards.
Construction Employment
Union Labor & Earnings, 2015-20
Pharmaceutical & Biotech
Oregon Construction Labor Hours by Trade
Pharmaceutical & Biotech, 2015-20
8,732
Installation
1,410
Maintenance
10,143
Total hours
Largest Construction Projects
Pharmaceutical & Biotech Manufacturing, 2015-20
Genentech (Roche USA) Incorporated
4625 NE Brookwood Pkwy, Hillsboro, OR 97124, USA
Hillsboro Biopharmaceutical Fill/Finish-Technical OPS Plant "Inest" Building Add
Hillsboro, OR
$170,000,000
2019-2021
Genentech (Roche USA) Incorporated
4625 NE Brookwood Pkwy, Hillsboro, OR 97124, USA
Hillsboro Biotherapeutic Fill/Finish Plant Life Bldg 2 Production Suite Addition
Hillsboro, OR
$125,000,000
2016-2017
Bend Research, a division of Capsugel
63045 NE Corporate Pl, Bend, OR 97701, USA
Bend Solid Oral Dose and HPAPI Development Plant Addition
Bend, OR
$35,000,000
2017-2019
Bend Research, a division of Capsugel
63045 NE Corporate Pl, Bend, OR 97701, USA
Bend Pilot-Scale Solid Oral Dose CMO Plant Expansion
Bend, OR
$25,000,000
2014-2015
Patheon, part of Thermo Fisher Scientific
62925 NE 18th St, Bend, OR 97701, USA
Bend Pre-Clinical Oral, Solids, Capsules, Liquid CDMO Spray Drying Line Add+Reno
Bend, OR
$5,700,000
2016-2018
Genentech (Roche USA) Incorporated
Hillsboro Biopharmaceutical Fill/Finish-Technical OPS Plant "Inest" Building Add
Hillsboro, OR
Location
$170,000,000
Project Value
2019-2021
Years
Genentech (Roche USA) Incorporated
Hillsboro Biopharmaceutical Fill/Finish-Technical OPS Plant "Inest" Building Add
Genentech (Roche USA) Incorporated
Hillsboro Biotherapeutic Fill/Finish Plant Life Bldg 2 Production Suite Addition
Bend Research, a division of Capsugel
Bend Solid Oral Dose and HPAPI Development Plant Addition
Hillsboro, OR
Location
$170,000,000
Project Value
2019-2021
Years
Hillsboro, OR
Location
$125,000,000
Project Value
2016-2017
Years
Bend, OR
Location
$35,000,000
Project Value
2017-2019
Years
Bend Research, a division of Capsugel
Bend Pilot-Scale Solid Oral Dose CMO Plant Expansion
Patheon, part of Thermo Fisher Scientific
Bend Pre-Clinical Oral, Solids, Capsules, Liquid CDMO Spray Drying Line Add+Reno
Bend, OR
Location
$25,000,000
Project Value
2014-2015
Years
Bend, OR
Location
$5,700,000
Project Value
2016-2018
Years
Genentech (Roche USA) Incorporated
Hillsboro Biopharmaceutical Fill/Finish-Technical OPS Plant "Inest" Building Add
Hillsboro, OR
Location
$170,000,000
Project Value
2019-2021
Years
Genentech (Roche USA) Incorporated
Hillsboro Biotherapeutic Fill/Finish Plant Life Bldg 2 Production Suite Addition
Hillsboro, OR
Location
$125,000,000
Project Value
2016-2017
Years
Bend Research, a division of Capsugel
Bend Solid Oral Dose and HPAPI Development Plant Addition
Bend, OR
Location
$35,000,000
Project Value
2017-2019
Years
Bend Research, a division of Capsugel
Bend Pilot-Scale Solid Oral Dose CMO Plant Expansion
Bend, OR
Location
$25,000,000
Project Value
2014-2015
Years
Patheon, part of Thermo Fisher Scientific
Bend Pre-Clinical Oral, Solids, Capsules, Liquid CDMO Spray Drying Line Add+Reno
Bend, OR
Location
$5,700,000
Project Value
2016-2018
Years